Nevertheless, we found markedly lower levels of IFNG-induced chemokine CXCL10 in KD and CXCL9 and IL15 in both KD and severe COVID-19, suggesting blunted type II interferon signaling in both KD and severe COVID-19 conditions. The gene discussed is CXCL9; the disease is COVID-19.